Listening Visits for Emotionally Distressed Mothers of Hospitalized Newborns

NCT03704948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2023-09-29

Study results available
· View outcomes & findings →

Summary

The proposed research has potential to dramatically improve care for emotionally distressed mothers of newborns hospitalized on the neonatal intensive care unit (NICU). Clinical NICU nurses are well-positioned to provide emotional support in the form of Listening Visits. Specifically, these nurses are easily accessible to NICU mothers, are often the most trusted professional on the healthcare team, they are knowledgeable about the newborn's medical conditions, and, finally they are already skilled in the art of warm communication. This intervention should not only improve depressive outcomes in emotionally distressed NICU mothers but also indirectly impact maternal perception of nurse support which is in turn related to depression symptoms and patient satisfaction, as well as infant length of stay by accelerating maternal readiness for infant discharge.

Conditions

  • Nurse Delivered Counseling
  • Emotional Distress

Interventions

BEHAVIORAL

RCT Treatment -Listening Visits delivered by NICU nurse in person

6 sessions, approximately one hour in length, delivered by a nurse who uses empathic listening and problem solving.

BEHAVIORAL

RCT Control Usual mental health care delivered by NICU social workers

RCT Control Usual mental health care delivered by NICU social workers

BEHAVIORAL

Open trial: Listening Visits delivered by a NICU nurse via zoom

Open trial: Listening Visits delivered by a NICU nurse via zoom

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH
  • University of Iowa

    lead OTHER

Principal Investigators

  • Lisa S. Segre, PhD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-14
Primary Completion
2022-06-20
Completion
2022-06-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03704948 on ClinicalTrials.gov